Fonte dei dati: Archivio della Ricerca http://art.torvergata.it

1. Gatti, V., Bongiorno-Borbone, L., Fierro, C., Annicchiarico-Petruzzelli, M., Melino, G., & Peschiaroli, A. (2019). p63 at the Crossroads between Stemness and Metastasis in Breast Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(11) [10.3390/ijms20112683]. Dettagli
2. Orienti, I., Francescangeli, F., De Angelis, M.L., Fecchi, K., Bongiorno-Borbone, L., Signore, M., et al. (2019). A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors. CELL DEATH & DISEASE, 10 [10.1038/s41419-019-1775-y]. Dettagli
3. Orienti, I., Salvati, V., Sette, G., Zucchetti, M., Bongiorno-Borbone, L., Peschiaroli, A., et al. (2019). A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 38(1) [10.1186/s13046-019-1383-9]. Dettagli
4. Gatti, V., Fierro, C., Compagnone, M., Giangrazi, F., Markert, E.K., Bongiorno-Borbone, L., et al. (2018). Delta Np63 regulates the expression of hyaluronic acid-related genes in breast cancer cells. ONCOGENESIS, 7, 65 [10.1038/s41389-018-0073-3]. Dettagli
5. Compagnone, M., Gatti, V., Presutti, D., Ruberti, G., Fierro, C., Markert, E.K., et al. (2017). ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 114(50), 13254-13259. Dettagli
6. Bongiorno-Borbone, L., Giacobbe, A., Compagnone, M., Eramo, A., De Maria, R., Peschiaroli, A., et al. (2015). Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells. ONCOTARGET, 6(19), 16926-16938 [10.18632/oncotarget.4700]. Dettagli
7. De Cola, A., Bongiorno-Borbone, L., Bianchi, E., Barcaroli, D., Carletti, E., Knight, R.A., et al. (2012). FLASH is essential during early embryogenesis and cooperates with p73 to regulate histone gene transcription. ONCOGENE, 31(5), 573-582 [10.1038/onc.2011.274]. Dettagli
8. Vernole P., Bongiorno-Borbone L., De Cola A., & De Laurenzi V. (2009). dinamic changes of cajal bodies and histone locus bodies during mitosis. : DNA repair defects and chromosomal fragile sites expression.. Paper presented at ICEM-10th International Conference on Environmental Mutagens, Firenze, Italia. Dettagli
9. Bongiorno-Borbone L., D.C.A. (2008). FLASH and NPAT positive but not Coilin positive Cajal Bodies correlate with cell ploidy. CELL CYCLE, 7(15), 2357-2367. Dettagli
10. L. Bongiorno-Borbone L., A.D.C. (2008). FLASH/NPAT positive but not Coilin positive Cajal Bodies correlate with cell ploidy.. Paper presented at ECWD, Germania. Dettagli
11. Vernole, P., Bongiorno Borbone, L., De Cola, A., Barcaroli, D., Melino, G., & De Laurenzi, V. (2008). FLASH positive but not coilin positive cajal bodies correlate with cell ploidy.. Paper presented at Int Symp. On Cancer genotypes and phenotypes., Firenze. Dettagli
12. Barcaroli D., D.D. (2006). FLASH is an essential component of Cajal bodies. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 103(40), 14802-14807 [10.1073/pnas.0604225103]. Dettagli
13. Bongiorno Borbone, L., Kadare, G., Benfenati, F., & Girault, J.A. (2005). FAK and PYK2 interact with SAP90/PSD-95-Associated Protein-3. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 337(2), 641-646. Dettagli
    

    10.1016/j.bbrc.2005.09.099

    Citazione

    Bongiorno Borbone, L., Kadare, G., Benfenati, F., & Girault, J.A. (2005). FAK and PYK2 interact with SAP90/PSD-95-Associated Protein-3. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 337(2), 641-646.

    Data

    2005

    id

    PUBBLICAZIONE_24520

    Tipologia

    Articolo su rivista

    SSD

    Settore BIO/11

    Tutti gli Autori

    FAK and PYK2 interact with SAP90/PSD-95-Associated Protein-3

    tipologia

    Bongiorno Borbone, L; Kadare, G; Benfenati, F; Girault, JA
14. Ciafrè, S.A., Barillari, G., Bongiorno-Borbone, L., Wannenes, F., Izquierdo, M., & Farace, M.G. (2002). A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo. GENE THERAPY, 9(4), 297-302 [10.1038/sj.gt.3301652]. Dettagli
15. Ciafrè, S.A., Barillari, G., Wannenes, F., Bongiorno-Borbone, L., & Farace, M.G. (2000). Multicistronic antiangiogenic retroviral vectors for the gene therapy of malignant brain tumors. CANCER GENE THERAPY, 7(10), 1395-1396. Dettagli